Search Results - "Van de Waterbeemd, B"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Adaptive immune response to whole cell pertussis vaccine reflects vaccine quality: A possible complementation to the Pertussis Serological Potency test by Hoonakker, M.E, Verhagen, L.M, van der Maas, L, Metz, B, Uittenbogaard, J.P, van de Waterbeemd, B, van Els, C.A.C.M, van Eden, W, Hendriksen, C.F.M, Sloots, A, Han, W.G.H

    Published in Vaccine (17-08-2016)
    “…Abstract Whole cell Bordetella pertussis (wP) vaccines are still used in many countries to protect against the respiratory disease pertussis. The potency of…”
    Get full text
    Journal Article
  2. 2

    practical approach for exploration and modeling of the design space of a bacterial vaccine cultivation process by Streefland, M, Van Herpen, P.F.G, Van de Waterbeemd, B, Van der Pol, L.A, Beuvery, E.C, Tramper, J, Martens, D.E, Toft, M

    Published in Biotechnology and bioengineering (15-10-2009)
    “…A licensed pharmaceutical process is required to be executed within the validated ranges throughout the lifetime of product manufacturing. Changes to the…”
    Get full text
    Journal Article
  3. 3

    Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process by van de Waterbeemd, Bas, Streefland, Mathieu, van der Ley, Peter, Zomer, Bert, van Dijken, Harry, Martens, Dirk, Wijffels, René, van der Pol, Leo

    Published in Vaccine (05-07-2010)
    “…Abstract The use of detergent-extracted outer membrane vesicles (OMVs) is an established approach for development of a multivalent PorA vaccine against N…”
    Get full text
    Journal Article
  4. 4

    Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis by van de Waterbeemd, Bas, Zomer, Gijsbert, Kaaijk, Patricia, Ruiterkamp, Nicole, Wijffels, René H, van den Dobbelsteen, Germie P J M, van der Pol, Leo A

    Published in PloS one (31-05-2013)
    “…An improved detergent-free process has been developed to produce vaccine based on native outer membrane vesicles (NOMV) against Neisseria meningitidis…”
    Get full text
    Journal Article
  5. 5

    Quantitative Proteomics Reveals Distinct Differences in the Protein Content of Outer Membrane Vesicle Vaccines by van de Waterbeemd, Bas, Mommen, Geert P. M, Pennings, Jeroen L. A, Eppink, Michel H, Wijffels, René H, van der Pol, Leo A, de Jong, Ad P. J. M

    Published in Journal of proteome research (05-04-2013)
    “…At present, only vaccines containing outer membrane vesicles (OMV) have successfully stopped Neisseria meningitidis serogroup B epidemics. These vaccines…”
    Get full text
    Journal Article
  6. 6

    Identification and optimization of critical process parameters for the production of NOMV vaccine against Neisseria meningitidis by van de Waterbeemd, Bas, Streefland, Mathieu, van Keulen, Lonneke, van den IJssel, Jan, de Haan, Alex, Eppink, Michel H, van der Pol, Leo A

    Published in Vaccine (21-05-2012)
    “…Highlights ► We optimized detergent-free OMV extraction for vaccine production. ► Two critical process parameters were identified (harvest point and extraction…”
    Get full text
    Journal Article
  7. 7

    Unbiased Selective Isolation of Protein N-Terminal Peptides from Complex Proteome Samples Using Phospho Tagging PTAG) and TiO2-based Depletion by Mommen, G.P.M, Waterbeemd, B., van de, Meiring, H.D, Kersten, G, Heck, A.J.R, Jong, A.P.J.M., de

    Published in Molecular & cellular proteomics (2012)
    “…A positional proteomics strategy for global N-proteome analysis is presented based on phospho tagging (PTAG) of internal peptides followed by depletion by…”
    Get full text
    Journal Article
  8. 8

    Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine development by van de Waterbeemd, Bas, Zomer, Gijsbert, van den Ijssel, Jan, van Keulen, Lonneke, Eppink, Michel H, van der Ley, Peter, van der Pol, Leo A

    Published in PloS one (23-01-2013)
    “…Outer membrane vesicles (OMV) contain immunogenic proteins and contribute to in vivo survival and virulence of bacterial pathogens. The first OMV vaccines…”
    Get full text
    Journal Article
  9. 9

    Gene-expression-based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production by van de Waterbeemd, Bas, Streefland, Mathieu, Pennings, Jeroen, van der Pol, Leo, Beuvery, Coen, Tramper, Johannes, Martens, Dirk

    Published in Biotechnology and bioengineering (01-08-2009)
    “…The evolution of vaccine product quality during batch cultivation of Bordetella pertussis, the causative agent of whooping cough, was investigated with the…”
    Get full text
    Journal Article
  10. 10

    PAT for vaccines: The first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease by Streefland, Mathieu, van de Waterbeemd, Bas, Happé, Hester, van der Pol, Leo A, Beuvery, E. Coen, Tramper, Johannes, Martens, Dirk E

    Published in Vaccine (20-04-2007)
    “…Abstract Since variation in process time and process output is commonly accepted to be inevitable for biological processes, application of Process Analytical…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Expression of phosphofructokinase in Neisseria meningitidis by Baart, Gino J. E, Langenhof, Marc, van de Waterbeemd, Bas, Hamstra, Hendrik-Jan, Zomer, Bert, van der Pol, Leo A, Beuvery, E. C, Tramper, Johannes, Martens, Dirk E

    “…1 Netherlands Vaccine Institute (NVI), Unit Research and Development, PO Box 457, 3720 AL Bilthoven, The Netherlands 2 Wageningen University, Food and…”
    Get full text
    Journal Article
  12. 12

    Evaluation of a critical process parameter: Oxygen limitation during cultivation has a fully reversible effect on gene expression of Bordetella pertussis by Streefland, Mathieu, van de Waterbeemd, Bas, Kint, Joeri, van der Pol, Leo A, Beuvery, E. Coen, Tramper, Johannes, Martens, Dirk E

    Published in Biotechnology and bioengineering (2009)
    “…Modern (bio)pharmaceutical process development requires thorough investigation of all process parameters that are critical to product quality. The impact of a…”
    Get full text
    Journal Article
  13. 13